EQS-PVR: Marinomed Biotech AG: Release according to Article 135, Section 2 BörseG with the objective of Europe-wide distribution

Oct 24 2024 11:00 BSTSource: EQS

EQS Voting Rights Announcement: Marinomed Biotech AG
Marinomed Biotech AG: Release according to Article 135, Section 2 BörseG with the objective of Europe-wide distribution

24.10.2024 / 12:00 CET/CEST
Dissemination of a Voting Rights Announcement transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Major holdings notification pursuant to Sec. 130 to 134 BörseG 2018

Wien, 23.10.2024

Overview

☐ Notification made after deadline

Caution: In case of violations of major holdings notification rules, please pay attention to Section 137 BörseG 2018 (Suspension of voting rights)

1. Issuer: Marinomed Biotech AG

2. Reason for the notification: Acquisition or disposal of voting rights

3. Person subject to notification obligation
Name: LLB Invest Kapitalanlagegesellschaft m.b.H.
City: Wien
Country: Österreich

4. Name of shareholder(s):

5. Date on which the threshold was crossed or reached: 23.10.2024

6. Total positions

	% of voting rights attached to shares (7.A)	% of voting rights through financial/other instruments (7.B.1 + 7.B.2)	Total of both in % (7.A + 7.B)	Total number of voting rights of issuer
Resulting situation on the date on which threshold was crossed / reached	10,01 %	0,00 %	10,01 %	1 694 583
Position of previous notification (if applicable)	9,81 %

Details

7. Notified details of the resulting situation:

A: Voting rights attached to shares
ISIN Code	Number of voting rights		% of voting rights
	Direct (Sec 130 BörseG 2018)	Indirect (Sec 133 BörseG 2018)	Direct (Sec 130 BörseG 2018)	Indirect (Sec 133 BörseG 2018)
ATMARIONOMED6		169 666		10,01 %
SUBTOTAL A	169 666		10,01 %

B 1: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1 BörseG 2018
Type of instrument	Expiration Date	Exercise Period	Number of voting rights that may be acquired if the instrument is exercised	% of voting rights

		SUBTOTAL B.1

B 2: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG 2018
Type of instrument	Expiration Date	Exercise Period	Physical / Cash Settlement	Number of voting rights	% of voting rights

			SUBTOTAL B.2

8. Information in relation to the person subject to the notification obligation:

☒ Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

☐ Full chain of controlled undertakings through which the voting rights and/or the financial/other instruments are effectively held starting with the ultimate controlling natural person or legal entity:

9. In case of proxy voting

Date of general meeting: -

Voting rights after general meeting: - is equivalent to - voting rights.

10. Sonstige Kommentare:

Die LLB Invest Kapitalanlagegesellschaft m.b.H. hält genannte Aktien als Verwaltungsgesellschaft (KAG) von Investmentfonds. Es gilt hinsichtlich der Zurechnung/Kontrolle die Ausnahme nach § 134 Abs 2 BörseG und § 8 TransV 2018.

Wien am 23.10.2024

24.10.2024 CET/CEST

Language:	English
Company:	Marinomed Biotech AG
	Hovengasse 25
	2100 Korneuburg
	Austria
Internet:	www.marinomed.com


End of News	EQS News Service

2015487 24.10.2024 CET/CEST